J, E., IA, A., P, S., T, W., N, S., K, A., . . . JUS, J. (2022). Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): Can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial. Trials, 23(1), 817. https://doi.org/10.1186/s13063-022-06720-z
Chicago Style (17th ed.) CitationJ, Eklöf, et al. "Targeted AntiBiotics for Chronic Pulmonary Diseases (TARGET ABC): Can Targeted Antibiotic Therapy Improve the Prognosis of Pseudomonas Aeruginosa-infected Patients with Chronic Pulmonary Obstructive Disease, Non-cystic Fibrosis Bronchiectasis, and Asthma? A Multicenter, Randomized, Controlled, Open-label Trial." Trials 23, no. 1 (2022): 817. https://doi.org/10.1186/s13063-022-06720-z.
MLA (9th ed.) CitationJ, Eklöf, et al. "Targeted AntiBiotics for Chronic Pulmonary Diseases (TARGET ABC): Can Targeted Antibiotic Therapy Improve the Prognosis of Pseudomonas Aeruginosa-infected Patients with Chronic Pulmonary Obstructive Disease, Non-cystic Fibrosis Bronchiectasis, and Asthma? A Multicenter, Randomized, Controlled, Open-label Trial." Trials, vol. 23, no. 1, 2022, p. 817, https://doi.org/10.1186/s13063-022-06720-z.
